Alpha 2.0
Login Register
» Articles » PMID: 20230369

Hot Topic: Biology in Anticancer Treatment

Overview
Journal Curr Cancer Drug Targets
Publisher Bentham Science Publishers
Specialty Oncology
Date 2010 Mar 17
PMID 20230369
Citations 3
Authors
Bruno Vincenzi
Affiliations
Soon will be listed here.
Citing Articles

HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.

Wang D, Qian G, Zhang H, Magliocca K, Nannapaneni S, Amin A Clin Cancer Res. 2016; 23(3):677-686.

PMID: 27358485 PMC: 5199640. DOI: 10.1158/1078-0432.CCR-16-0558.

Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.

Nema R, Vishwakarma S, Agarwal R, Panday R, Kumar A Onco Targets Ther. 2016; 9:3269-80.

PMID: 27330306 PMC: 4898435. DOI: 10.2147/OTT.S99989.

Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.

Kondaskar A, Kondaskar S, Kumar R, Fishbein J, Muvarak N, Lapidus R ACS Med Chem Lett. 2011; 2(3):252-256.

PMID: 21572541 PMC: 3092706. DOI: 10.1021/ml100281b.